Scott Koenig - 27 Jan 2023 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
Director
Signature
/s/ Brian F. Leaf, attorney-in-fact
Issuer symbol
GLYC
Transactions as of
27 Jan 2023
Net transactions value
+$26,775
Form type
4
Filing time
30 Jan 2023, 15:13:27 UTC
Previous filing
01 Dec 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLYC Common Stock Options Exercise $26,775 +10,500 +200% $2.55 15,750 27 Jan 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLYC Stock Option (right to buy) Options Exercise $0 -10,500 -100% $0.000000* 0 27 Jan 2023 Common Stock 10,500 $2.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vested on May 18, 2022 and are fully exercisable.